Kardia™ 12L: Next-Generation 12-Lead ECG System

The Kardia 12L represents an innovative advancement in ECG technology, addressing traditional challenges such as lead misplacement, patient discomfort, and spatial limitations. Utilizing a simplified five-electrode system, this next-generation 12-lead ECG device can diagnose 35 cardiac conditions, including acute myocardial infarction and cardiac ischemia. Its single-cable design ensures precise and efficient data capture, allowing clinicians to prioritize patient care. Portable and battery-operated, the Kardia 12L is ideal for various research settings, offering rapid disease detection and actionable insights. FDA-cleared and validated against over 1.75 million ECG datasets, the device leverages advanced AI algorithms to deliver reliability and accuracy on par with leading ECG solutions. Designed for seamless integration into clinical trials, the Kardia 12L enhances trial efficiency with flexible data integration and straightforward site setup, significantly improving patient comfort and the overall research process.